CA Stock MarketDetailed Quotes

Xtacy Therapeutics Corp (XTCY)

Watchlist
  • 0.030
  • 0.0000.00%
15min DelayMarket Closed Nov 4 09:38 ET
1.74MMarket Cap0.00P/E (TTM)

Xtacy Therapeutics Corp (XTCY) Key Financial Indicators

XTCY Earnings per Share (EPS)

According to the latest financial report of Xtacy Therapeutics Corp, the latest earnings per share (TTM) for the company is -0.00. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CAD

Quarterly

Loading...

XTCY Free Cash Flow (FCF)

Interested in knowing about Xtacy Therapeutics Corp's free cash flow? The latest report shows it as -216.70K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: CAD

Quarterly

Loading...

XTCY Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Xtacy Therapeutics Corp shows that the company's current ratio is 0.14, indicating healthy liquidity.

Currency: CAD

Quarterly

Loading...

XTCY Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Xtacy Therapeutics Corp, the quick ratio is 0.08, indicating that the company can meet its short-term debt obligations.

Currency: CAD

Quarterly

Loading...

XTCY Return on Equity (ROE)

Want to learn more about the financial health of Xtacy Therapeutics Corp? The latest ROE figure is -356.69%, indicating that the company has stable profitability.

Currency: CAD

Quarterly

Loading...

XTCY Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Xtacy Therapeutics Corp, the total asset return on investment (ROA) is -30.75%.

Currency: CAD

Quarterly

Loading...

XTCY Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Xtacy Therapeutics Corp's latest financial report to see how their gross margin is doing - currently at 77.01%.

Currency: CAD

Quarterly

Loading...

XTCY Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Xtacy Therapeutics Corp, the net profit margin is -1.06K%, which is a good sign for its profitability.

Currency: CAD

Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More